Simultaneous double primary malignant tumors of MSS/pMMR ascending colon cancer and MSI-H/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case report

The exceedingly rare clinical presentation of synchronous ascending colon carcinoma with duodenal adenocarcinoma demonstrating discordant mismatch repair protein expression patterns forms the cornerstone of this investigation. Through detailed analysis of a unique case featuring co-occurring MSS/pMM...

Full description

Saved in:
Bibliographic Details
Main Authors: Weimin Wang, Quan Yang, Yifan He, Xuefeng Cha, Chaoxian Xiong, Xiaoxia Li, Jie Li, Pin Gao, Kun Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1573580/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850123750317490176
author Weimin Wang
Quan Yang
Yifan He
Xuefeng Cha
Chaoxian Xiong
Xiaoxia Li
Jie Li
Pin Gao
Kun Yu
author_facet Weimin Wang
Quan Yang
Yifan He
Xuefeng Cha
Chaoxian Xiong
Xiaoxia Li
Jie Li
Pin Gao
Kun Yu
author_sort Weimin Wang
collection DOAJ
description The exceedingly rare clinical presentation of synchronous ascending colon carcinoma with duodenal adenocarcinoma demonstrating discordant mismatch repair protein expression patterns forms the cornerstone of this investigation. Through detailed analysis of a unique case featuring co-occurring MSS/pMMR ascending colon adenocarcinoma and MSI-H/dMMR duodenal adenocarcinoma, this study demonstrates the successful implementation of multidisciplinary therapeutic protocols achieving 22-month progression-free survival post-radical resection. These clinical findings offer empirical evidence for optimizing clinical management while systematically addressing diagnostic complexities and treatment dilemmas inherent to synchronous dual primary intestinal carcinomas. Particular emphasis is placed on reconciling therapeutic conflicts arising from differential tumor biology and developing precision strategies for molecularly heterogeneous synchronous malignancies.
format Article
id doaj-art-2bf63262925447658bf2fed1b7f48ee1
institution OA Journals
issn 2234-943X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-2bf63262925447658bf2fed1b7f48ee12025-08-20T02:34:32ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-05-011510.3389/fonc.2025.15735801573580Simultaneous double primary malignant tumors of MSS/pMMR ascending colon cancer and MSI-H/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case reportWeimin WangQuan YangYifan HeXuefeng ChaChaoxian XiongXiaoxia LiJie LiPin GaoKun YuThe exceedingly rare clinical presentation of synchronous ascending colon carcinoma with duodenal adenocarcinoma demonstrating discordant mismatch repair protein expression patterns forms the cornerstone of this investigation. Through detailed analysis of a unique case featuring co-occurring MSS/pMMR ascending colon adenocarcinoma and MSI-H/dMMR duodenal adenocarcinoma, this study demonstrates the successful implementation of multidisciplinary therapeutic protocols achieving 22-month progression-free survival post-radical resection. These clinical findings offer empirical evidence for optimizing clinical management while systematically addressing diagnostic complexities and treatment dilemmas inherent to synchronous dual primary intestinal carcinomas. Particular emphasis is placed on reconciling therapeutic conflicts arising from differential tumor biology and developing precision strategies for molecularly heterogeneous synchronous malignancies.https://www.frontiersin.org/articles/10.3389/fonc.2025.1573580/fullsynchronous double primary cancerscolorectal cancersmall intestinal cancermultidisciplinary team (MDT)case report
spellingShingle Weimin Wang
Quan Yang
Yifan He
Xuefeng Cha
Chaoxian Xiong
Xiaoxia Li
Jie Li
Pin Gao
Kun Yu
Simultaneous double primary malignant tumors of MSS/pMMR ascending colon cancer and MSI-H/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case report
Frontiers in Oncology
synchronous double primary cancers
colorectal cancer
small intestinal cancer
multidisciplinary team (MDT)
case report
title Simultaneous double primary malignant tumors of MSS/pMMR ascending colon cancer and MSI-H/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case report
title_full Simultaneous double primary malignant tumors of MSS/pMMR ascending colon cancer and MSI-H/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case report
title_fullStr Simultaneous double primary malignant tumors of MSS/pMMR ascending colon cancer and MSI-H/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case report
title_full_unstemmed Simultaneous double primary malignant tumors of MSS/pMMR ascending colon cancer and MSI-H/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case report
title_short Simultaneous double primary malignant tumors of MSS/pMMR ascending colon cancer and MSI-H/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case report
title_sort simultaneous double primary malignant tumors of mss pmmr ascending colon cancer and msi h dmmr duodenal cancer with nearly 2 years of recurrence free survival after mdt guided comprehensive treatment a case report
topic synchronous double primary cancers
colorectal cancer
small intestinal cancer
multidisciplinary team (MDT)
case report
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1573580/full
work_keys_str_mv AT weiminwang simultaneousdoubleprimarymalignanttumorsofmsspmmrascendingcoloncancerandmsihdmmrduodenalcancerwithnearly2yearsofrecurrencefreesurvivalaftermdtguidedcomprehensivetreatmentacasereport
AT quanyang simultaneousdoubleprimarymalignanttumorsofmsspmmrascendingcoloncancerandmsihdmmrduodenalcancerwithnearly2yearsofrecurrencefreesurvivalaftermdtguidedcomprehensivetreatmentacasereport
AT yifanhe simultaneousdoubleprimarymalignanttumorsofmsspmmrascendingcoloncancerandmsihdmmrduodenalcancerwithnearly2yearsofrecurrencefreesurvivalaftermdtguidedcomprehensivetreatmentacasereport
AT xuefengcha simultaneousdoubleprimarymalignanttumorsofmsspmmrascendingcoloncancerandmsihdmmrduodenalcancerwithnearly2yearsofrecurrencefreesurvivalaftermdtguidedcomprehensivetreatmentacasereport
AT chaoxianxiong simultaneousdoubleprimarymalignanttumorsofmsspmmrascendingcoloncancerandmsihdmmrduodenalcancerwithnearly2yearsofrecurrencefreesurvivalaftermdtguidedcomprehensivetreatmentacasereport
AT xiaoxiali simultaneousdoubleprimarymalignanttumorsofmsspmmrascendingcoloncancerandmsihdmmrduodenalcancerwithnearly2yearsofrecurrencefreesurvivalaftermdtguidedcomprehensivetreatmentacasereport
AT jieli simultaneousdoubleprimarymalignanttumorsofmsspmmrascendingcoloncancerandmsihdmmrduodenalcancerwithnearly2yearsofrecurrencefreesurvivalaftermdtguidedcomprehensivetreatmentacasereport
AT pingao simultaneousdoubleprimarymalignanttumorsofmsspmmrascendingcoloncancerandmsihdmmrduodenalcancerwithnearly2yearsofrecurrencefreesurvivalaftermdtguidedcomprehensivetreatmentacasereport
AT kunyu simultaneousdoubleprimarymalignanttumorsofmsspmmrascendingcoloncancerandmsihdmmrduodenalcancerwithnearly2yearsofrecurrencefreesurvivalaftermdtguidedcomprehensivetreatmentacasereport